187 related articles for article (PubMed ID: 18712675)
1. The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma?
Burns JS; Abdallah BM; Schrøder HD; Kassem M
Histol Histopathol; 2008 Oct; 23(10):1229-40. PubMed ID: 18712675
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells.
Burns JS; Abdallah BM; Guldberg P; Rygaard J; Schrøder HD; Kassem M
Cancer Res; 2005 Apr; 65(8):3126-35. PubMed ID: 15833842
[TBL] [Abstract][Full Text] [Related]
3. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy.
Gjerstorff M; Burns JS; Nielsen O; Kassem M; Ditzel H
Am J Pathol; 2009 Jul; 175(1):314-23. PubMed ID: 19498007
[TBL] [Abstract][Full Text] [Related]
5. Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction.
Burns JS; Kristiansen M; Kristensen LP; Larsen KH; Nielsen MO; Christiansen H; Nehlin J; Andersen JS; Kassem M
PLoS One; 2011; 6(7):e21888. PubMed ID: 21779348
[TBL] [Abstract][Full Text] [Related]
6. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.
Lee TH; Bolontrade MF; Worth LL; Guan H; Ellis LM; Kleinerman ES
Int J Cancer; 2006 Aug; 119(4):839-46. PubMed ID: 16557578
[TBL] [Abstract][Full Text] [Related]
7. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.
Wang Y; Huso DL; Harrington J; Kellner J; Jeong DK; Turney J; McNiece IK
Cytotherapy; 2005; 7(6):509-19. PubMed ID: 16306013
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
Yamaoka E; Hiyama E; Sotomaru Y; Onitake Y; Fukuba I; Sudo T; Sueda T; Hiyama K
Int J Oncol; 2011 Jul; 39(1):5-11. PubMed ID: 21573488
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
11. Chromosome copy number variation in telomerized human bone marrow stromal cells; insights for monitoring safe ex-vivo expansion of adult stem cells.
Burns JS; Harkness L; Aldahmash A; Gautier L; Kassem M
Stem Cell Res; 2017 Dec; 25():6-17. PubMed ID: 28988007
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.
Abdallah BM; Haack-Sørensen M; Burns JS; Elsnab B; Jakob F; Hokland P; Kassem M
Biochem Biophys Res Commun; 2005 Jan; 326(3):527-38. PubMed ID: 15596132
[TBL] [Abstract][Full Text] [Related]
13. Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells.
Pan Q; Fouraschen SM; de Ruiter PE; Dinjens WN; Kwekkeboom J; Tilanus HW; van der Laan LJ
Exp Biol Med (Maywood); 2014 Jan; 239(1):105-15. PubMed ID: 24227633
[TBL] [Abstract][Full Text] [Related]
14. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
15. MIC2 detection in tumors of bone and adjacent soft tissues.
Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
[TBL] [Abstract][Full Text] [Related]
16. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic profile and FISH analysis in a case of Ewing's sarcoma.
Papadopoulos N; Tamiolakis D; Lambropoulou M; Alexiadis G; Argyropoulou P; Manavis J; Verettas D; Sivridis E
In Vivo; 2001; 15(4):359-64. PubMed ID: 11695230
[TBL] [Abstract][Full Text] [Related]
18. Adult human mesenchymal stem cell as a target for neoplastic transformation.
Serakinci N; Guldberg P; Burns JS; Abdallah B; Schrødder H; Jensen T; Kassem M
Oncogene; 2004 Jun; 23(29):5095-8. PubMed ID: 15107831
[TBL] [Abstract][Full Text] [Related]
19. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
20. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.
Yu L; Su B; Hollomon M; Deng Y; Facchinetti V; Kleinerman ES
Cancer Res; 2010 Feb; 70(4):1334-43. PubMed ID: 20124484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
